Accuray, RaySearch Expand Deal in $8M Adaptive Radiotherapy Push
Image
Madison, Wis. – September 16, 2026 -- Accuray Incorporated (NASDAQ: ARAY) and RaySearch Laboratories AB (publ) have signed a definitive agreement expanding their collaboration to accelerate adoption of online adaptive radiation therapy, with Accuray committing to purchase RayStation software licenses valued at $8 million.
Accuray commits $8 million to RaySearch software licenses
Under the deal, Accuray will buy specified RayStation licenses to support commercialization of online adaptive radiation therapy solutions, which both companies will jointly market and support. The agreement also brings RaySearch's RayCare technology into the partnership to simplify connectivity between clinical systems and streamline adaptive workflows.